Drug and Therapeutics Bulletin 1998;36:73-76; doi:10.1136/dtb.1998.361073
Copyright © 1998 by the BMJ Publishing Group Ltd.

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation

The place of pneumococcal vaccination

Relevant BNF section: 14.4

Vaccination against pneumococcal infection was introduced in the UK in 1979. Currently, the vaccine is recommended by the Department of Health for patients at high risk of developing pneumococcal infection.¹ Here we discuss the epidemiology of pneumococcal infection and consider the effectiveness of the vaccines available and their use in clinical practice.

This article has been cited by other articles:

				R. Pistelli, P. Lange, and D.L. Miller Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity Eur. Respir. J., May 1, 2003; 21(40_suppl): 10S - 14s. [Abstract] [Full Text] [PDF]

				S. W.-L. Soh, C. L. Poh, and R. V. T. P. Lin Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Isolates from Pediatric Patients in Singapore Antimicrob. Agents Chemother., August 1, 2000; 44(8): 2193 - 2196. [Abstract] [Full Text]